Chinese Journal of Stroke ›› 2023, Vol. 18 ›› Issue (10): 1175-1180.DOI: 10.3969/j.issn.1673-5765.2023.10.010

Previous Articles     Next Articles

Interpretation of the Updates on Standards for Reporting Vascular Changes on Neuroimaging 2

YE Jinyi1*, CHEN Weiqi1,2*, WANG Yilong1,2,3,4,5,6,7 (*Contributed equally)   

  • Received:2023-08-16 Online:2023-10-20 Published:2023-10-20

脑小血管病国际影像标准2更新要点解读

叶瑾怡1*,陈玮琪1,2*,王伊龙1,2,3,4,5,6,7(*第一作者)   

  1. 1 北京 100070首都医科大学附属北京天坛医院神经病学中心
    2 临床流行病学北京市重点实验室
    3 北京脑科学与类脑研究所
    4 国家神经疾病医学中心
    5 首都医科大学人脑保护高精尖创新中心
    6 国家神经系统疾病临床医学研究中心
    7 口腔健康北京实验室
  • 通讯作者: 王伊龙 yilong528@aliyun.com
  • 基金资助:
    国家自然科学基金委员会
    杰出青年科学基金项目(81825007)
    北京高校卓越青年科学家计划项目BJJWZYJH01201910025030
    首都卫生发展科研专项(首发-2022-2-2045)
    科技部国家重点研发计划(2022YFF1501500;2022YFF1501501;2022YFF1501502;2022YFF1501503;2022YFF1501504;2022YFF1501505)
    青年北京学者(No.010)

Abstract: Cerebral small vessel disease (CSVD) is a common disease in the aging process that would result in stroke, cognitive disorder, neuropsychological disorders or symptoms, and other functional impairments. CSVD often co-exists with neurodegenerative diseases, further exacerbating cognitive impairment or other symptoms that affect the patient's ability to live independently. Standards for reporting vascular changes on neuroimaging 1 (STRIVE-1) classifies and standardizes the different features of CSVD seen on structural MRI. The STRIVE-2, published in 2023, further updates the neuroimaging guidelines for vascular changes in CSVD. This paper will explain the update points of STRIVE-2.

Key words: Cerebral small vessel disease; Consensus; Neuroimaging

摘要: 脑小血管病(cerebral small vessel disease,CSVD)是衰老过程中的常见疾病,可能会导致卒中、认知障碍、神经心理疾病或症状以及其他功能损害。CSVD常与神经退行性疾病并存,进一步加重认知损害及其他症状的发生,从而影响患者的日常生活能力。脑小血管病国际影像标准 1(standards for reporting vascular changes on neuroimaging-1,STRIVE-1)对结构MRI上所见的CSVD不同影像特征进行了分类和标准化。2023年发布的STRIVE-2进一步更新了CSVD血管变化的神经影像学指南。本文将对STRIVE-2更新要点进行解读。

关键词: 脑小血管病; 共识; 神经影像